Abstract: A computer-implemented method provides a requested medical data record to a receiving entity. The method includes receiving a set of medical data records and receiving or initiating a joint data index and, for each medical data record of the set, applying a plurality of hash functions to a patient identifier corresponding to the medical data record to determine a hash vector, the patient identifier corresponding to the medical data record identifying the patient being subject of the medical data record, and updating the joint data index based on the hash vector. Furthermore, it includes providing the joint data index to the receiving entity and receiving a request for a record, corresponding to a request patient identifier and being based on the joint data index, from the receiving entity. The method includes providing the requested medical data record to the receiving entity via a secure communication channel.

Abstract: Methods are disclosed for setting up a microservice, enhancing a ledger of microservices with a further microservice and accessing medical datasets stored in a microservice. The microservice contains the medical dataset in an encrypted form. The microservice includes an access logic based on accessing entity information. The access logic defines access conditions to the medical dataset and is configured to grant access to the medical dataset upon the access conditions being fulfilled.

Abstract: The invention relates to esterquats which can be obtained by reacting di- or trialkanolamines with a mixture of fatty acids and polycarboxylic acids, and the esters obtained in this manner are then quaternized with an alkylating agent, wherein the di- or trialkanolamines correspond to formula (I), in which R1 and R2 independently of one another represent hydroxyalkyl groups with 1 to 20 carbon atoms, hydroxyalkenyl groups with 2 to 20 carbon atoms and 1, 2, or 3 double bonds, or addition products of 1 to 20 mol ethylene oxide on a hydroxyethyl group and R3 represents hydrogen, an alkyl group with 1 to 20 carbon atoms, an alkenyl group with 2 to 20 carbon atoms and 1, 2, or 3 double bonds, a hydroxyalkyl group with 1 to 20 carbon atoms, a hydroxyalkenyl group with 2 to 20 carbon atoms and 1, 2, or 3 double bonds, or addition products of 1 to 20 mol ethylene oxide on a hydroxyethyl group; the fatty acids correspond to formula (II), R4—COOH??(II) in which R4 represents an aliphatic, linear, or branched hyd

Abstract: A computer-implemented method provides a requested medical data record to a receiving entity. The method includes receiving a set of medical data records and receiving or initiating a joint data index and, for each medical data record of the set, applying a plurality of hash functions to a patient identifier corresponding to the medical data record to determine a hash vector, the patient identifier corresponding to the medical data record identifying the patient being subject of the medical data record, and updating the joint data index based on the hash vector. Furthermore, it includes providing the joint data index to the receiving entity and receiving a request for a record, corresponding to a request patient identifier and being based on the joint data index, from the receiving entity. The method includes providing the requested medical data record to the receiving entity via a secure communication channel.

Abstract: The invention relates to esterquats which can be obtained by reacting di- or trialkanolamines with a mixture of fatty acids and polycarboxylic acids, and the esters obtained in this manner are then quaternized with an alkylating agent, wherein the di- or trialkanolamines correspond to formula (I), in which R1 and R2 independently of one another represent hydroxyalkyl groups with 1 to 20 carbon atoms, hydroxyalkenyl groups with 2 to 20 carbon atoms and 1, 2, or 3 double bonds, or addition products of 1 to 20 mol ethylene oxide on a hydroxyethyl group and R3 represents hydrogen, an alkyl group with 1 to 20 carbon atoms, an alkenyl group with 2 to 20 carbon atoms and 1, 2, or 3 double bonds, a hydroxyalkyl group with 1 to 20 carbon atoms, a hydroxyalkenyl group with 2 to 20 carbon atoms and 1, 2, or 3 double bonds, or addition products of 1 to 20 mol ethylene oxide on a hydroxyethyl group; the fatty acids correspond to formula (II), R4—COOH (II) in which R4 represents an aliphatic, linear, or branched hyd

Abstract: Methods are disclosed for setting up a microservice, enhancing a ledger of microservices with a further microservice and accessing medical datasets stored in a microservice. The microservice contains the medical dataset in an encrypted form. The microservice includes an access logic based on accessing entity information. The access logic defines access conditions to the medical dataset and is configured to grant access to the medical dataset upon the access conditions being fulfilled.

Abstract: A method and a device for handling sample tubes are presented. A position of the sample tube is identified and the sample tube is handled depending thereon.

Abstract: A method and a device for handling sample tubes are presented. A position of the sample tube is identified and the sample tube is handled depending thereon.

Abstract: A laboratory sample distribution system and a laboratory automation system comprising such a laboratory sample distribution system are presented. The laboratory sample distribution system comprises a number of sample container carriers adapted to move autonomously and to communicate with each other and with a central control unit.

Abstract: This invention relates to a collector composition for the direct froth flotation of nonsulfide ores comprising a) 50-99 wt.-% of a mixture of fatty acids and b) 1-50 wt.-% of an N-acyl derivative of sarcosine of the formula (I) wherein R is a saturated or unsaturated hydrocarbon chain with 7 to 21 carbon atoms, wherein the mixture of comprises 10.0-35.0 wt.-% of fatty acid having a saturated C11 hydrocarbon group, 2.5-15.0 wt.-% of fatty acid having a saturated C13 hydrocarbon group, 10.0-25.0 wt.-% fatty acid having a monounsaturated C17 hydrocarbon group and 20.0-45.0 wt.-% fatty acid having a bisunsaturated C17 hydrocarbon group.

Abstract: A method of operating a laboratory automation system is presented. The laboratory automation system comprises a plurality of laboratory stations and a plurality of sample container carriers. The sample container carriers carry one or more sample containers. The sample containers comprise samples to be analyzed by the laboratory stations. The system also comprises a transport plane. The transport plane supports the sample container carriers. The system also comprises a drive. The drive moves the sample container carriers on the transport plane. The method comprises, during an initialization of the laboratory automation system, logically reserving at least one buffer area on the transport plane and, after the initialization of the laboratory automation system, buffering in the at least one buffer area sample container carriers carrying sample containers comprising samples waiting for a result of an analysis. Depending on the result of the analysis, the samples are further processed.

Abstract: A laboratory sample distribution system is presented. The system comprises sample container carriers carrying a sample container and comprising a magnetically active device. The system also comprises a transport plane supporting the sample container carriers and comprises drive modules comprising first line shaped conductors extending in a first direction and arranged parallel to each other and second line shaped conductors extending in a second direction and arranged parallel to each other. The system comprises a driver electrically connected to each of the first and second conductors of the drive modules. The driver selectively applies a drive current and/or voltage to the first and second conductors such that a conductor current results in the conductors driven by the drive current and/or voltage. The conductor current selectively causes a drive force to the sample container carriers such that the sample container carriers move along individual transport paths on the transport plane.

Abstract: This invention relates to a collector composition for the direct froth flotation of nonsulfide ores comprising a) 50-99 wt.-% of a mixture of fatty acids and b) 1-50 wt.-% of an N-acyl derivative of sarcosine of the formula (I) wherein R is a saturated or unsaturated hydrocarbon chain with 7 to 21 carbon atoms, wherein the mixture of comprises 10.0-35.0 wt.-% of fatty acid having a saturated C11 hydrocarbon group, 2.5-15.0 wt.-% of fatty acid having a saturated C13 hydrocarbon group, 10.0-25.0 wt.-% fatty acid having a monounsaturated C17 hydrocarbon group and 20.0-45.0 wt.-% fatty acid having a bisunsaturated C17 hydrocarbon group.

Abstract: A system and method for treating Parkinson's disease by delivery of an agent within the brain. At least one image of a target region is acquired, and at least one magnetic resonance diffusion tensor imaging (MR-DTI) scan of the target region is acquired. A diffusion tensor is calculated from the at least one MR-DTI scan, and at least one of an agent distribution and an agent concentration from the images and the calculated diffusion tensor is calculated. Using at least one of the calculated diffusion tensor, the images, the calculated agent distribution, and the calculated agent concentration, the placement of a delivery instrument is planned to deliver the agent to the target region to achieve a desired agent concentration and/or agent distribution within the target region. Delivery of the agent can be coordinated with an applied electrical stimulation.

Abstract: A system and method for treating Alzheimer's disease by delivery of an agent within the brain. At least one image of a target region is acquired, and at least one magnetic resonance diffusion tensor imaging (MR-DTI) scan of the target region is acquired. A diffusion tensor is calculated from the at least one MR-DTI scan, and at least one of an agent distribution and an agent concentration from the images and the calculated diffusion tensor is calculated. Using at least one of the calculated diffusion tensor, the images, the calculated agent distribution, and the calculated agent concentration, the placement of a delivery instrument is planned to deliver the agent to the target region to achieve a desired agent concentration and/or agent distribution within the target region.

Abstract: A system and method for treating Amyotrophic Lateral Sclerosis (ALS) by delivery of an agent within the brain. At least one image of a target region is acquired, and at least one magnetic resonance diffusion tensor imaging (MR-DTI) scan of the target region is acquired. A diffusion tensor is calculated from the at least one MR-DTI scan, and at least one of an agent distribution and an agent concentration from the images and the calculated diffusion tensor is calculated. Using at least one of the calculated diffusion tensor, the images, the calculated agent distribution, and the calculated agent concentration, the placement of a delivery instrument is planned to deliver the agent to the target region to achieve a desired agent concentration and/or agent distribution within the target region.

Abstract: A method for planning an infusion into hepatic tissue into a patient includes: obtaining anatomical and/or physiological patient data of the patient's liver or a region of the liver; determining at least one patient parameter from the patient data; planning the infusion using the anatomical patient data, physiological patient data, and/or at least one patient parameter, wherein planning includes determining how an administered substance is distributed in the tissue and/or how the administered substance influences physiological properties of the tissue; and determining a distribution and/or effectiveness of a therapeutic agent administered with the substance or after the substance.

Abstract: A laboratory sample distribution system and a laboratory automation system comprising such a laboratory sample distribution system are presented. The laboratory sample distribution system comprises a number of sample container carriers adapted to move autonomously and to communicate with each other and with a central control unit.

Abstract: A laboratory sample distribution system is presented. The system comprises sample container carriers carrying a sample container and comprising a magnetically active device. The system also comprises a transport plane supporting the sample container carriers and comprises drive modules comprising first line shaped conductors extending in a first direction and arranged parallel to each other and second line shaped conductors extending in a second direction and arranged parallel to each other. The system comprises a driver electrically connected to each of the first and second conductors of the drive modules. The driver selectively applies a drive current and/or voltage to the first and second conductors such that a conductor current results in the conductors driven by the drive current and/or voltage. The conductor current selectively causes a drive force to the sample container carriers such that the sample container carriers move along individual transport paths on the transport plane.

Abstract: A method of operating a laboratory automation system is presented. The laboratory automation system comprises a plurality of laboratory stations and a plurality of sample container carriers. The sample container carriers carry one or more sample containers. The sample containers comprise samples to be analyzed by the laboratory stations. The system also comprises a transport plane. The transport plane supports the sample container carriers. The system also comprises a drive. The drive moves the sample container carriers on the transport plane. The method comprises, during an initialization of the laboratory automation system, logically reserving at least one buffer area on the transport plane and, after the initialization of the laboratory automation system, buffering in the at least one buffer area sample container carriers carrying sample containers comprising samples waiting for a result of an analysis. Depending on the result of the analysis, the samples are further processed.